Furthermore, of the 12 patients in our cohort who were hospitalised with COVID-19, 100% (12/12) were positive for SARS-CoV-2 IL-2 T cell responses while only 50% (6/12) were antibody seropositive (Figure 5b,c). This evidence concerns the gene IL2 and COVID-19.